- Time-Sensitive Medical Care
Oncofertility: Protecting Your Fertility Before Cancer Treatment Begins
Oncofertility is the specialised field that helps cancer patients preserve their fertility before chemotherapy, radiation, or surgery permanently damages eggs, sperm, or reproductive organs. Because many cancers are now highly curable, preserving the ability to have biological children after recovery has become a recognised part of comprehensive cancer care. At Samarth IVF, oncofertility consultations are scheduled within 48 to 72 hours of referral. Options include egg freezing, embryo freezing, sperm banking, and ovarian tissue cryopreservation.
URGENT: Fertility preservation must happen BEFORE cancer treatment begins. Once chemotherapy or radiation starts, the window to preserve fertility may close permanently.
What is Oncofertility?
Oncofertility bridges two medical specialties that historically operated independently oncology (cancer care) and reproductive medicine (fertility). It addresses one key problem: cancer treatments, while life-saving, frequently damage or destroy reproductive function in patients of reproductive age. As cancer survival rates have improved dramatically over recent decades, the quality of life of survivors including the ability to have biological children has become a clinical priority.
The American Society of Clinical Oncology (ASCO) recommends that all cancer patients of reproductive age receive fertility preservation counselling before treatment begins as a standard of care. This guidance applies regardless of whether the patient currently wants children – because preferences can change after recovery, and the window to preserve fertility closes once treatment starts.
How Cancer Treatments Damage Fertility
Chemotherapy
Chemotherapy drugs target rapidly dividing cells. Since developing egg follicles and sperm-producing cells divide constantly, they are vulnerable to chemotherapy damage. The degree of fertility damage depends on the drug type, cumulative dose, patient age, and pre-treatment fertility status.
- Alkylating agents (cyclophosphamide, busulfan, chlorambucil, melphalan, ifosfamide) are the most harmful to ovaries and testes – they cause direct DNA damage to primordial follicles and spermatogonial stem cells
- Platinum-based agents (cisplatin, carboplatin) – moderate to high gonadotoxicity
- Anthracyclines (doxorubicin) – moderate risk depending on cumulative dose
- Taxanes (paclitaxel, docetaxel) – lower risk but not zero
- Targeted therapies and immunotherapy – variable and still being studied; sperm banking is always advisable
Radiation Therapy
Radiation effects depend on field, dose, and scatter. Pelvic radiation for cervical, uterine, rectal, bladder, or prostate cancers directly exposes the gonads and reproductive organs. Even low doses (6 to 8 Gy) can cause ovarian failure. Testicular damage is dose-dependent. Total body irradiation (TBI) used before bone marrow transplants causes permanent ovarian failure and severe testicular damage in almost all cases – one of the highest-risk scenarios in oncofertility.
- Cranial radiation affecting the hypothalamus or pituitary – disrupts hormonal control of reproduction causing secondary hypogonadism
- Spinal radiation – risk depends on field proximity to gonads
- Scatter radiation from nearby fields – can reduce ovarian or testicular function even when gonads are not directly in the field
Surgery
- Bilateral oophorectomy – immediate surgical menopause and permanent loss of egg production
- Hysterectomy – permanent loss of ability to carry pregnancy (eggs can still be frozen for gestational surrogacy)
- Radical trachelectomy for cervical cancer – may preserve uterus but reduce cervical function needed for pregnancy
- Bilateral orchiectomy – permanent loss of sperm production
- Retroperitoneal lymph node dissection – may damage nerves controlling ejaculation, causing retrograde ejaculation or anejaculation
Cancer Treatment Fertility Risk at a Glance
| Treatment / Cancer Type | Fertility Risk | Recommended Preservation |
|---|---|---|
| Alkylating chemotherapy | Very High | Egg/embryo freeze, sperm banking |
| Pelvic radiation | Very High | Egg freeze, ovarian transposition, shielding |
| Total body irradiation | Very High (near universal sterility) | Ovarian tissue cryo + sperm banking urgently |
| Platinum-based chemo | Moderate to High | Egg/embryo freeze, sperm banking |
| Testicular cancer (bilateral) | High | Sperm banking urgently before surgery |
| Breast cancer | Moderate to High | Egg freeze with letrozole protocol |
| Hodgkin lymphoma | Moderate to High | Egg/embryo freeze, sperm banking |
| Targeted therapies | Variable | Sperm banking; egg freeze if possible |
- For Women
Fertility Preservation Options for Female Cancer Patients
Egg Freezing (Oocyte Cryopreservation) - Gold Standard
For women who have 8 to 14 days before cancer treatment begins, egg freezing is the most established and successful preservation option. The process is identical to an IVF stimulation cycle: injectable hormone medications to grow multiple follicles, follicle monitoring scans every 2 to 3 days, egg retrieval under IV sedation, and vitrification (ultra-rapid freezing) of mature eggs.
Hormone-sensitive cancers:
For hormone-sensitive cancers (oestrogen-receptor positive breast cancer, uterine cancer), standard stimulation raises oestrogen significantly. Modified protocols using letrozole (an aromatase inhibitor) during stimulation minimise the oestrogen rise while still achieving adequate follicle development. Multiple studies confirm letrozole protocols do not compromise cancer outcomes. Always disclose your cancer type and receptor status to your fertility specialist before starting.
Embryo Freezing
Women with male partners or willing to use donor sperm can freeze embryos instead of eggs. Embryos survive freezing and thawing at a marginally higher rate than unfertilised eggs. The stimulation and retrieval process is identical to egg freezing.
Embryo freezing requires partner or donor selection at this stage – if the relationship ends or the partner dies, the disposition of jointly-owned embryos requires both parties’ consent per clinic protocols. Single women or those uncertain about partners typically prefer egg freezing for flexibility.
Ovarian Tissue Cryopreservation
For Urgent Cases: Involves surgically removing one ovary or strips of ovarian cortex through laparoscopy before cancer treatment. The tissue is frozen and stored. After recovery, it is re-implanted, restoring natural fertility for several years.
- No stimulation required (can be done in 24-48 hrs).
- The only option for prepubescent girls.
- Caveat: risk of reintroducing cancer cells in haematological malignancies.
Ovarian Suppression (GnRH Agonists)
Using GnRH agonists during chemotherapy temporarily suppresses ovarian activity, potentially protecting follicles from chemotherapy damage. Evidence is mixed. This is considered an adjunctive strategy and should not replace egg or embryo freezing when either is feasible.
Ovarian Transposition (Oophoropexy)
For pelvic radiation. Surgeons laparoscopically move the ovaries out of the radiation field (into the paracolic gutters). This reduces the ovarian radiation dose and can preserve function. Useful when eggs cannot be frozen before radiation.
- For Men
Fertility Preservation Options for Male Cancer Patients
Sperm Banking - Simple, Fast, Essential
Sperm banking is the simplest, fastest, and most effective fertility preservation for male cancer patients. Men produce a semen sample through masturbation, which is processed and cryopreserved within hours. The process can be completed in a single clinic visit and can be arranged within 1 to 2 days even in urgent situations. Multiple samples (2 to 5 vials) are typically banked on consecutive days if time permits.
Every male cancer patient who has reached puberty should be offered sperm banking – regardless of cancer type, current relationship status, or stated intentions about future children. Post-thaw sperm survival averages 40 to 60 percent, which is more than sufficient for IVF-ICSI. Success rates with banked sperm match fresh sperm rates.
Surgical Sperm Retrieval
When ejaculation is not possible.
- Electroejaculation: for spinal cord injury patients.
- TESE: retrieval from testicular tissue.
- PESA: fine needle aspiration of epididymis.
Testicular Tissue Cryopreservation
For prepubescent boys who cannot produce mature sperm. Testicular tissue is removed and frozen to preserve spermatogonial stem cells. Offered at specialised centres as the only option for boys facing sterilising treatment.
Timing: The Most Critical Factor inOncofertility
The window between cancer diagnosis and treatment initiation determines which preservation options are available. The good news: most cancers allow time for preservation. Research consistently shows that 2 to 3 week delays for egg freezing, or 1 to 2 day delays for sperm banking, do not compromise survival outcomes for the majority of cancer types.
Cancers That Typically Allow Time for Egg Freezing
Breast cancer (most Stage I to III) - 2 to 4 weeks is generally acceptable
Hodgkin and non-Hodgkin lymphoma - 2 to 3 weeks typically acceptable
Testicular cancer - sperm banking before or after orchiectomy; egg freezing is a separate process for female partners
Thyroid cancer - surgery often semi-elective; egg/sperm banking easily accommodated
Colorectal cancer - typically allows 2 to 3 weeks
Cervical cancer (early stage) - usually allows time for egg freezing
Cancers Requiring Near-Immediate Treatment
Acute leukaemias (AML, ALL) -
treatment must begin within days; egg freezing usually not possible; sperm banking within 24 hours often achievable; ovarian tissue removal can sometimes be done at the same time as another necessary procedure
Rapidly growing aggressive lymphomas -
some allow only 7 to 10 days
Inflammatory breast cancer -
often requires rapid treatment initiation
At Samarth IVF, oncofertility consultations are scheduled within 48 to 72 hours of referral. For very urgent cases, we can initiate preservation protocols within 24 to 48 hours. Contact us directly by phone for urgent referrals rather than waiting for an online booking appointment.
Financial Assistance forOncofertility Patients
Cost is a real barrier for cancer patients already facing overwhelming medical expenses. Samarth IVF offers significantly reduced pricing for oncofertility preservation cases. Our team will guide you through all available cost reduction options at your first consultation
Samarth IVF Oncofertility Programme:
Reduced rates on egg freezing, embryo freezing, and sperm banking for confirmed cancer patients — contact us directly for current pricing.
First-year storage fee waiver:
Or reduction for cancer patients in active treatment.
Livestrong Fertility (international):
Partners with fertility clinics to offer deeply discounted or free preservation for cancer patients.
Ferring Heart Beat Programme:
Medication cost assistance for fertility preservation cycles.
Pharmaceutical patient assistance:
Major fertility medication manufacturers offer free or reduced-cost medications for qualifying patients.
Hospital social workers:
Many cancer centres can help identify assistance programmes — ask your oncology team.
Oncofertility Services atSamarth IVF Centres
Oncofertility consultations, egg freezing, embryo freezing, and sperm banking are available at Samarth IVF centres across India. For urgent cases, please call the nearest centre directly. Our embryology and andrology labs are equipped for immediate commencement of preservation protocols.
Sambhajinagar (Aurangabad), Maharashtra: Main HQ with full surgical and IVF facilities, plus 2 Level-1 Centres
Washim, Maharashtra | Buldhana, Maharashtra | Parbhani, Maharashtra | Omerga (Umarga), Maharashtra | Gondia, Maharashtra
Dehradun, Uttarakhand | Jamnagar, Gujarat | Kalaburagi (Gulbarga), Karnataka | Bhopal, Madhya Pradesh | Farrukhabad, Uttar Pradesh | Lucknow, Uttar Pradesh
- FAQ
FREQUENTLY ASKED QUESTIONS
Oncofertility is a specialised field combining oncology and reproductive medicine. It helps cancer patients of reproductive age preserve their fertility before cancer treatments (chemotherapy, radiation, or surgery) that can permanently damage eggs, sperm, or reproductive organs. The goal is to ensure that cancer survivors retain the option to have biological children after recovery.
Immediately. Fertility preservation must happen before cancer treatment begins. Once chemotherapy or radiation starts, the opportunity to preserve eggs, sperm, or embryos may be permanently lost. Even if treatment begins in 1 to 2 weeks, sperm banking can be completed in 1 to 2 days, and ovarian tissue removal can sometimes be arranged in 24 to 48 hours. Contact Samarth IVF as soon as you receive your diagnosis.
Not always. Some chemotherapy regimens cause temporary fertility loss with recovery over 6 to 24 months after treatment ends. Others, particularly alkylating agents, pelvic radiation, and total body irradiation, cause permanent damage. The specific drugs, doses, radiation fields, and your pre-treatment fertility status all affect outcomes. This uncertainty is exactly why preserving before treatment is so important - it is your insurance against permanent loss.
Yes. Modified stimulation protocols using letrozole (an aromatase inhibitor) during ovarian stimulation minimise the oestrogen rise, making egg freezing safer for oestrogen-receptor positive breast cancer. Multiple studies have confirmed that letrozole protocols do not compromise cancer outcomes. Ensure your oncologist and fertility specialist communicate before stimulation begins.
Yes. Eggs and sperm are frozen before cancer treatment begins, so they are not exposed to chemotherapy or radiation. Research on pregnancies from cancer survivors consistently shows no increased rates of birth defects or health problems in children compared to the general population. The frozen eggs or sperm are from your healthy pre-treatment reproductive cells.
One week is very tight for egg freezing (which typically needs 8 to 14 days), but it depends on where you are in your menstrual cycle. Sperm banking can always be completed in 1 to 3 days. Ovarian tissue cryopreservation (a single laparoscopy requiring no stimulation) can sometimes be arranged within 24 to 48 hours. Contact Samarth IVF immediately - every day matters and options exist even for short windows.
For girls who have reached puberty, egg or embryo freezing may be possible depending on ovarian development and the time available before treatment. For prepubescent girls, ovarian tissue cryopreservation is the primary option - ovarian cortex strips are frozen and can be re-implanted after recovery to restore ovarian function. Refer to a specialised fertility centre experienced in paediatric oncofertility as early as possible after diagnosis.
For most cancer types, pregnancy after recovery is considered medically safe. ASCO guidelines recommend waiting 2 years post-treatment before attempting conception for most cancers, to confirm remission and reduce relapse risk. For hormone-sensitive cancers (especially oestrogen-receptor positive breast cancer), longer waiting periods are usually recommended. Your oncologist will guide the appropriate timeline based on your specific cancer and treatment.
Yes. Samarth IVF offers significantly reduced pricing for oncofertility preservation cases for confirmed cancer patients. We also assist in identifying external financial assistance programmes including Livestrong Fertility and pharmaceutical patient assistance schemes. Contact us directly at your nearest centre to discuss costs and assistance options.
If you have already started chemotherapy, the sperm available may have reduced quality due to early treatment effects. Banking is still worthwhile if sperm can be collected - even a small number of viable sperm can be used for IVF-ICSI. However, the best time to bank is always before treatment begins. If you have not yet banked, contact us immediately to assess your current situation.
Act Now to Protect Your Future.
Oncofertility is time-sensitive. We schedule urgent consults within 48-72 hours.
